Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ezetimibe in STEMI (OCTIVUS)
NCT01385631Phase 4Completed
- Sponsor
- University Hospital Odense
- Start
- Jun 2011
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in ST elevation myocardial infarction (STEMI) comparing Atorvastatin plus Ezetimibe with Atorvastatin plus Placebo (2 arms). Primary endpoint: Plaque volume and composition in a non-significant coronary plaque at 12 months. Started Jun 2011; status: completed.
02
Drugs
ezetimibe
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT01385631.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01385631.